NCT06760000

Brief Summary

The goal of this observational study is to explore the long-term health outcomes of sleep disorders in adults aged 18 and older, as well as to identify associated biomarkers and risk factors. The main questions it aims to answer are:

  • What are the long-term health risks associated with sleep disorders, such as cognitive decline, cardiovascular diseases, or metabolic conditions?
  • Are there specific biomarkers or patterns that can predict the onset or progression of sleep disorders? Participants diagnosed with sleep disorders (e.g., insomnia, sleep apnea) or identified as healthy controls will undergo home-based sleep monitoring and complete clinical assessments at baseline and during follow-ups over a 3-year period. Biological samples, including blood and stool, will also be collected to analyze potential biomarkers. Data will be used to develop predictive models for sleep disorder risk and outcomes.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
68mo left

Started Aug 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Aug 2024Dec 2031

Study Start

First participant enrolled

August 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 6, 2025

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2031

Last Updated

January 6, 2025

Status Verified

December 1, 2024

Enrollment Period

6.4 years

First QC Date

December 29, 2024

Last Update Submit

December 29, 2024

Conditions

Keywords

Sleep DisorderHome MonitoringMulticenter Longitudinal Cohort

Outcome Measures

Primary Outcomes (1)

  • Incidence of Sleep Disorders and Related Diseases

    * Measure the occurrence of sleep disorders and related diseases, including cognitive decline, cardiovascular diseases, and metabolic conditions, over the follow-up period. * Data will be collected through clinical evaluations, sleep monitoring (e.g., polysomnography, wearable devices), and laboratory analyses (e.g., blood biomarkers). * Key metrics include the development or progression of these conditions, assessed through standardized diagnostic criteria.

    36 months (Baseline and follow-ups at 12, 24, and 36 months)

Interventions

Non-contact mat monitoring sleep data through pulse wave detection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will include adults aged 18 years and older, recruited from two primary sources: clinical sleep centers and online advertisements. Participants will be divided into two groups: those diagnosed with sleep disorders, including insomnia, sleep apnea, and parasomnia, and healthy controls with no clinical symptoms. Individuals with sleep disorders will be identified through polysomnography or equivalent diagnostic methods, ensuring accurate categorization. Recruitment will target a diverse population to reflect a broad range of demographic and lifestyle factors, such as age, gender, and socio-economic background. The healthy control group will include individuals diagnosed as free from sleep-related conditions during clinical evaluations or through self-reported health statuses verified by researchers. Exclusion criteria include individuals with severe mental illnesses (e.g., bipolar disorder, schizophrenia), infectious diseases (e.g., tuberculosis, HIV/AIDS), pregnan

You may qualify if:

  • Willing to voluntarily participate in the study and provide signed informed consent.
  • Gender is not restricted, and baseline age is 18 years or older.
  • Experiencing sleep disorders and capable of complying with the study procedures and tests.

You may not qualify if:

  • Diagnosed with severe mental health conditions, such as bipolar disorder, schizophrenia, or claustrophobia.
  • Suffering from infectious diseases, including tuberculosis, HIV/AIDS, or syphilis.
  • Pregnant women.
  • Experiencing acute inflammatory responses at the time of enrollment.
  • Long-term use of corticosteroids or undergoing hormone replacement therapy.
  • Determined by the researcher to be unsuitable for participation for any reason.
  • Patients with specific diseases (e.g., cardiovascular conditions) may be excluded if the study focuses on related comorbidities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Medical Technology, Peking University Health Science Center

Beijing, Beijing Municipality, 100191, China

Location

MeSH Terms

Conditions

Sleep Wake Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 29, 2024

First Posted

January 6, 2025

Study Start

August 1, 2024

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2031

Last Updated

January 6, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

We plan to share the individual participant data (IPD) that are necessary for presenting the results included in publications. This will include de-identified data related to key outcomes, such as demographic information, clinical assessments, and sleep monitoring results. Additional data beyond what is included in the publications may be available upon reasonable request. Researchers interested in accessing these data should contact the project lead, who will evaluate requests on a case-by-case basis to ensure compliance with ethical and legal guidelines.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations